C Bokemeyer
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Honecker F, Huddart R, Jewett M, Joly F, Lauritsen J, Lorch A, Necchi A, Nicolai N, Oing C, Oldenburg J, Ondruš D, Papachristofilou A, Powles T, Sohaib A, Ståhl O, Tandstad T, Toner G, Hemminki K, Heidenreich A, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann K, Fizazi K, Fosså S, Germà-Lluch J, Giannatempo P, Gietema J, Gillessen Sommer S, Haugnes H, Horwich A. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol 2018; 29:1658-1686.
Aug 1, 2018ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Aug 1, 2018Ann Oncol 2018; 29:1658-1686
Honecker F, Huddart R, Jewett M A S, Joly F, Lauritsen J, Lorch A, Necchi A, Nicolai N, Oing C, Oldenburg J, Ondruš D, Papachristofilou A, Powles T, Sohaib A, Ståhl O, Tandstad T, Toner G, Hemminki K, Heidenreich A, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann K-P, Fizazi K, Fosså S, Germà-Lluch J R, Giannatempo P, Gietema J A, Gillessen Sommer Silke, Haugnes H S, Horwich A
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Wittekind C, Nuver J, Nicolai N, Necchi A, Mayer F, Lotz J, Lorch A, Looijenga L, Laguna M, Krege S, Kollmannsberger C, Kliesch S, Huddart R, Oechsle K, Oldenburg J, Oosterhuis J, Winter C, Tandstad T, Souchon R, Sohaib A, Sedlmayer F, Schweyer S, Schrader M, Salvioni R, Rosti G, Rick O, Rajpert-De Meyts E, Powles T, Horwich A, Honecker F, Hentrich M, Daugaard G, Dahl A, Cohn-Cedermark G, Classen J, Clarke N, Cavallin-Stahl E, Cathomas R, Busch J, Bokemeyer C, Aparicio J, Altena R, Albers P, De Giorgi U, De Santis M, De Wit M, Heidenreich A, Hartmann J, Giwercman A, Gillessen S, Gietema J, Germá Lluch J, Fossa S, Fléchon A, Fizazi K, Fenner M, Dieckmann K, De Wit R, Beyer J. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2012; 24:878-88.
Nov 14, 2012Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Nov 14, 2012Ann Oncol 2012; 24:878-88
Wittekind C, Nuver J, Nicolai N, Necchi A, Mayer F, Lotz J P, Lorch A, Looijenga L H J, Laguna M P, Krege S, Kollmannsberger C, Kliesch S, Huddart R A, Oechsle K, Oldenburg J, Oosterhuis J W, Winter C, Tandstad T, Souchon R, Sohaib A, Sedlmayer F, Schweyer S, Schrader M, Salvioni R, Rosti G, Rick O, Rajpert-De Meyts E, Powles T, Horwich A, Honecker F, Hentrich M, Daugaard G, Dahl A A, Cohn-Cedermark G, Classen J, Clarke N W, Cavallin-Stahl E, Cathomas R, Busch J, Bokemeyer C, Aparicio J, Altena R, Albers P, De Giorgi U, De Santis M, De Wit M, Heidenreich A, Hartmann J T, Giwercman A, Gillessen S, Gietema J A, Germá Lluch J R, Fossa S D, Fléchon A, Fizazi K, Fenner M, Dieckmann K P, De Wit R, Beyer J
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
Hartmann J, Kollmannsberger C, Cascorbi I, Mayer F, Schittenhelm M, Heeger S, Bokemeyer C. A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer. Invest New Drugs 2012; 31:661-8.
Jul 26, 2012A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
Jul 26, 2012Invest New Drugs 2012; 31:661-8
Hartmann J T, Kollmannsberger C, Cascorbi I, Mayer F, Schittenhelm Marcus, Heeger S, Bokemeyer C
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
Reichmann U, Bokemeyer C, Wallwiener D, Bamberg M, Huober J. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007; 18:1981-4.
Dec 1, 2007Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
Dec 1, 2007Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007; 18:1981-4
Reichmann U, Bokemeyer C, Wallwiener D, Bamberg M, Huober Jens
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
Hartmann J, Oechsle K, Huober J, Jakob A, Azemar M, Horger M, Kanz L, Bokemeyer C. An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma. Investigational new drugs 2006; 24:249-53.
May 1, 2006An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
May 1, 2006Investigational new drugs 2006; 24:249-53
Hartmann J T, Oechsle K, Huober Jens, Jakob A, Azemar M, Horger M, Kanz L, Bokemeyer C
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
Kollmannsberger C, Schittenhelm M, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC). Ann Oncol 2006; 17:1007-13.
Mar 13, 2006A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
Mar 13, 2006Ann Oncol 2006; 17:1007-13
Kollmannsberger C, Schittenhelm Marcus, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 2003; 89:2133-9.
Dec 1, 2003Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
Dec 1, 2003Br J Cancer 2003; 89:2133-9
Koch S, Mayer F, Honecker F, Schittenhelm Marcus, Bokemeyer C